mofezolac has been researched along with fk 881 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fortuna, CG; Panella, A; Perrone, MG; Scilimati, A; Vitale, P | 1 |
| Bhardwaj, A; Kaur, J; Wuest, F | 1 |
2 other study(ies) available for mofezolac and fk 881
| Article | Year |
|---|---|
General role of the amino and methylsulfamoyl groups in selective cyclooxygenase(COX)-1 inhibition by 1,4-diaryl-1,2,3-triazoles and validation of a predictive pharmacometric PLS model.
Topics: Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Least-Squares Analysis; Molecular Structure; Reproducibility of Results; Structure-Activity Relationship; Triazoles | 2015 |
Development of Fluorescence Imaging Probes for Labeling COX-1 in Live Ovarian Cancer Cells.
Topics: | 2021 |